Cover Image
市場調查報告書

Ironwood Pharmaceuticals, Inc.的產品平台分析

Ironwood Pharmaceuticals, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 305185
出版日期 內容資訊 英文 38 Pages
訂單完成後即時交付
價格
Back to Top
Ironwood Pharmaceuticals, Inc.的產品平台分析 Ironwood Pharmaceuticals, Inc. - Product Pipeline Review - 2015
出版日期: 2015年05月27日 內容資訊: 英文 38 Pages
簡介

Ironwood Pharmaceuticals, Inc.ha是從事消化器官系統疾病用的醫藥品之研究、開發、商品化的製藥企業。。

本報告提供Ironwood Pharmaceuticals, Inc.上的治療藥開發平台現狀及各開發階段比較分析,提供藥物標的,作用機制,給藥途徑,各類型分子的治療藥評估,以及最新的企業新聞和發表,後期階段及中止計劃的相關資訊等。

Ironwood Pharmaceuticals, Inc.的基本資料

Ironwood Pharmaceuticals, Inc.概要

  • 主要資訊
  • 企業資料

Ironwood Pharmaceuticals, Inc.:R&D概要

  • 主要的治療範圍

Ironwood Pharmaceuticals, Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Ironwood Pharmaceuticals, Inc.:開發中產品概況

  • 位於最終階段的開發中產品
    • 位於第三階段的產品/聯合治療模式
  • 位於臨床實驗階段的開發中產品
    • 位於第二階段的產品/聯合治療模式
    • 位於第一階段的產品/聯合治療模式
  • 位於初期階段的開發中產品
    • 位於前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Ironwood Pharmaceuticals, Inc.:藥物簡介

  • linaclotide
  • IW-3718
  • IW-9179
  • IW-2143
  • Iw-Cpd-1
  • Iw-Cpd-2

Ironwood Pharmaceuticals, Inc.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各類型分子
  • 各作用機制

Ironwood Pharmaceuticals, Inc.:最近的開發平台趨勢

Ironwood Pharmaceuticals, Inc.:暫停中的計劃

Ironwood Pharmaceuticals, Inc.:企業發表

Ironwood Pharmaceuticals, Inc.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07111CDB

Summary

Global Markets Direct's, 'Ironwood Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Ironwood Pharmaceuticals, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Ironwood Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Ironwood Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Ironwood Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Ironwood Pharmaceuticals, Inc.'s pipeline products

Reasons to buy

  • Evaluate Ironwood Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Ironwood Pharmaceuticals, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Ironwood Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Ironwood Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ironwood Pharmaceuticals, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Ironwood Pharmaceuticals, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Ironwood Pharmaceuticals, Inc. Snapshot
    • Ironwood Pharmaceuticals, Inc. Overview
    • Key Information
    • Key Facts
  • Ironwood Pharmaceuticals, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Ironwood Pharmaceuticals, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Ironwood Pharmaceuticals, Inc. - Pipeline Products Glance
    • Ironwood Pharmaceuticals, Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Ironwood Pharmaceuticals, Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Ironwood Pharmaceuticals, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Ironwood Pharmaceuticals, Inc. - Drug Profiles
    • linaclotide
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IW-3718
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IW-9179
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IW-1973
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • IW-1701
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Ironwood Pharmaceuticals, Inc. - Pipeline Analysis
    • Ironwood Pharmaceuticals, Inc. - Pipeline Products by Target
    • Ironwood Pharmaceuticals, Inc. - Pipeline Products by Route of Administration
    • Ironwood Pharmaceuticals, Inc. - Pipeline Products by Molecule Type
    • Ironwood Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action
  • Ironwood Pharmaceuticals, Inc. - Recent Pipeline Updates
  • Ironwood Pharmaceuticals, Inc. - Company Statement
  • Ironwood Pharmaceuticals, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Ironwood Pharmaceuticals, Inc., Key Information
  • Ironwood Pharmaceuticals, Inc., Key Facts
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Indication, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Ironwood Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Ironwood Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015
  • Ironwood Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Ironwood Pharmaceuticals, Inc. - Phase III, 2015
  • Ironwood Pharmaceuticals, Inc. - Phase II, 2015
  • Ironwood Pharmaceuticals, Inc. - Phase I, 2015
  • Ironwood Pharmaceuticals, Inc. - Preclinical, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Target, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015
  • Ironwood Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015
  • Ironwood Pharmaceuticals, Inc., Subsidiaries

List of Figures

  • Ironwood Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015
  • Ironwood Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Ironwood Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top